Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
15.70
-0.72 (-4.38%)
At close: Dec 5, 2025, 4:00 PM EST
15.71
+0.01 (0.06%)
After-hours: Dec 5, 2025, 5:33 PM EST
COEP Employees
As of December 31, 2024, Coeptis Therapeutics Holdings had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$71,571
Profits / Employee
-$1,769,886
Market Cap
83.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | 0 | - |
| Dec 31, 2023 | 7 | 2 | 40.00% |
| Dec 31, 2022 | 5 | 0 | - |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COEP News
- 2 months ago - Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating - GlobeNewsWire
- 4 months ago - Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd - GlobeNewsWire
- 5 months ago - Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - GlobeNewsWire
- 6 months ago - Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology - GlobeNewsWire
- 8 months ago - Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement - GlobeNewsWire
- 8 months ago - COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology - GlobeNewsWire
- 9 months ago - Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline - GlobeNewsWire
- 9 months ago - COEPTIS' NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan - GlobeNewsWire